se continúa excluyendo a demasiados pacientes con contraindicaciones Las estrategias a utilizar para mejorar los resultados de la trombólisis deben. tiempos críticos para trombólisis en pacientes con EVC Trombólisis en evento vascular cerebral isquémico. . Contraindicaciones para trombólisis: even-. La trombolisis es un proceso o una forma de tratamiento con un objetivo principal de Las contraindicaciones absolutas de trombólisis incluyen los siguientes.

Author: Vilrajas Fegul
Country: Sao Tome and Principe
Language: English (Spanish)
Genre: Environment
Published (Last): 8 October 2005
Pages: 249
PDF File Size: 4.32 Mb
ePub File Size: 17.52 Mb
ISBN: 499-3-67964-527-2
Downloads: 9366
Price: Free* [*Free Regsitration Required]
Uploader: Nejind

Controversias en tromboembolismo pulmonar masivo. Controversies in massive pulmonary embolism. Massive tromholisis embolism PE is associated with high mortality.

There is still a broad assortment of severity classifications for patients with PE, which affects the choice of therapies to use. The main clinical criteria for defining a PE as massive is systemic arterial hypotension, which depends on the extent of vascular obstruction and the previous cardiopulmonary status. Right ventricular dysfunction is an important pathogenic element to define the severity of patients and short term clinical prognosis.

The recommended treatment is systemic thrombolysis, but in centers with experience and resources, radiological invasive therapies through catheters are useful alternatives that can be used as first choice tools in certain cases. Rev Med Chile ; Pulmonary embolism; Thrombectomy; Thrombolytic therapy. Por lo tanto, las contraindicaciones para la trombolisis suelen ser extrapoladas de datos obtenidos de estudios en pacientes con IAM con SDST 33,34 Tabla 2.

El uso de trombolisis debe ser considerado en forma individual en los pacientes con riesgo intermedio y no debe utilizarse en pacientes de bajo riesgo Tabla 3. Se observa gran defecto de llene en arteria pulmonar derecha.


Solamente el estudio de Verstraete et al. Hirsh J, Hoak J. Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals. Urokinase Pulmonary Embolism Trial. Resolution rate of acute pulmonary embolism in man.


N Engl J Med ; The clinical course of pulmonary embolism. Weekend versus weekday admission and mortality after acute pulmonary embolism. Clinical predictors for fatal pulmonary embolism in 15, patients with venous thrombo-embolism: Prognostic significance of right ventricular afterload stress detected by echocardiography in patients with clinically suspected pulmonary embolism. Management strategies and determinants of outcome in acute trombolidis pulmonary embolism: J Am Coll Cardiol ; Curr Opin Cardiol ; Mclntyre K, Sasahara AA.

Determinants of right ventricular function and hemodynamics after pulmonary embolism.

Controversias en tromboembolismo pulmonar masivo

contraindicacionss Right ventricular dysfunction persists following brief right ventricular pressure overload. Cardiovasc Res ; Progressive right ventricular failure is not explained by myocardial ischemia in a pig model of right ventricular pressure overload. Eur J Cardiothorac Surg ; Platelet activation in acute pulmonary embolism. J Thromb Haemost ; 5: Guidelines on the diagnosis and management of acute pulmonary embolism: Trimbolisis Heart J ; Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians.

Evidence-Based Clinical Practice Guidelines. Chest ; 2 Suppl: Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: Streptokinase and heparin versus heparin alone in massive pulmonary embolism: Tromvolisis Thromb Thrombolysis ; 2: Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonary embolism. Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism.

Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: Comparison of alteplase versus heparin for resolution of major pulmonary embolism.

Am J Cardiol ; The urokinase pulmonary embolism trial. A national cooperative study.

Manejo inicial del ictus isquémico agudo

Circulation ; 47 2 Suppl. Plasminogen activator Italian multicenter study 2.

A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. Thrombolytic therapy for pulmonary embolism. Frequency of intracranial hemorrhage and associated risk factors. Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: Risks for major bleeding from thrombolytic therapy in patients with acute pulmonary embolism.

  BS EN 13201-4 PDF

Ann Intern Med ; Management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart ; ; Diagnostic yield of CT pulmonary angiography and venography for thromboembolic disease. Natriuretic peptide type-B can be a marker of reperfusion in patients with pulmonary thromboembolism subjected to invasive treatment. Int J Cardiovasc Imaging Pulmonary embolism treated with se thrombolysis and mechanical fragmentation.

Report of one case. Vasc Interv Radiol ; Experience with Patients in a Single Centre. Arch Bronconeumol contraindicacions Catheter-tip embolectomy inthe management of acute massive pulmonary embolism. Teodoran T, Sobieszczyk P.

Prog Cardiovasc Dis ; Fava M, Loyola S. Applications of percutaneous mechanical thrombectomy in pulmonary embolism. Tech Vasc Interv Radiol. Catheter-directed therapy for the treatment of massive pulmonary embolism: Systematic review and meta-analysis of modern techniques.

J Vasc Interv Radiol ; Transvenous removal of pulmonary emboli by vacuum-cup catheter technique. J Surg Res ; 9: Catheter fragmentation of acute massive pulmonary thromboembolism: Br J Radiol ; Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment cntraindicaciones acute massive pulmonary embolism.

Management of unsuccessful thrombolysis in acute massive pulmonary embolism. Open pulmonary embolectomy for treatment of major pulmonary embolism.

Ann Thorac Surg ; Modern surgical treatment of massive pulmonary embolism: J Thorac Cardiovasc Surg ; Outcome of pulmonary embolectomy. Recibido el 29 de marzo deaceptado el 19 de julio de